Mental Health
Mental Health

Rising Testosterone Prescriptions for Women Spark Concerns Over Diagnosis Practices

By Dr. Nathan Cole ·

Off‑Label Use Fuels the Surge

The use of testosterone therapy in women has climbed steadily since 2016, according to a recent study in the Journal of Clinical Endocrinology & Metabolism . Researchers found that many prescriptions are issued without a confirmed diagnosis of hypoactive sexual desire disorder, the only condition officially supported by evidence for this treatment. The trend is evident across primary care and specialty clinics in the United States, where clinicians are increasingly turning to hormone therapy for a range of complaints.

The analysis examined prescription data from a national pharmacy database covering the period from 2016 to 2023. It revealed a 45 % increase in testosterone prescriptions for women, with the majority lacking a documented indication. Experts suggest that the rise may be driven by patient demand for „energy‑boosting” solutions and a growing belief that testosterone can improve mood, libido, and muscle tone. However, the lack of rigorous diagnostic criteria raises safety concerns, especially as long‑term effects on cardiovascular health and bone density remain uncertain.

Are Hormone Patches the Safer Alternative?

Physicians often cite „low libido” or „fatigue” as reasons for prescribing testosterone, even though these symptoms can stem from numerous other causes. Dr. Elena Ramirez, an endocrinologist at a Boston medical center, explained, „We see patients who are frustrated with persistent tiredness and reduced sexual desire. Testosterone feels like a quick fix, but without proper testing, we risk exposing them to unnecessary hormone fluctuations.” The study highlighted that only 22 % of the prescriptions were linked to a formal diagnosis of hypoactive sexual desire disorder, while the rest were based on patient-reported symptoms alone.

The data also showed regional variation, with higher prescription rates in the Midwest and South. Some clinicians attribute this to differing medical cultures and insurance coverage policies that favor hormone therapy over alternative interventions such as psychotherapy or lifestyle modifications.

A parallel development in hormone therapy involves the introduction of transdermal testosterone patches, marketed as a more controlled delivery method. Early trials suggest that patches can maintain steadier blood levels, potentially reducing peaks that cause side effects like acne or mood swings. Nonetheless, the new delivery system does not address the core issue of prescribing without a clear indication. Critics argue that improved administration may inadvertently legitimize off‑label use, making it harder to enforce evidence‑based prescribing standards.

What Does This Mean for Women’s Bone Health?

Recent research has linked prolonged testosterone exposure in women to changes in bone remodeling. While testosterone can increase bone mineral density in some contexts, inappropriate dosing may accelerate bone loss, especially when combined with other medications such as glucocorticoids. Dr. Maya Patel, a bone health specialist, warned, „We must monitor bone markers closely. Unchecked hormone therapy could paradoxically increase fracture risk, undermining the very health benefits patients seek.” The study calls for routine bone density scans for women on long‑term testosterone, regardless of the delivery method.

The growing prevalence of testosterone prescriptions without solid diagnostic backing underscores a need for stricter guidelines and better patient education. As clinicians balance patient demands with safety, the medical community may see tighter regulatory scrutiny and more robust clinical trials to define appropriate use.

Why are doctors prescribing testosterone without a formal diagnosis? Many clinicians respond to patient complaints of low libido or fatigue, viewing testosterone as a rapid solution despite limited evidence beyond hypoactive sexual desire disorder.

Frequently Asked Questions

Are testosterone patches safer than injections or gels? Patches provide steadier hormone levels, which can lessen some side effects, but they do not eliminate risks associated with unnecessary hormone exposure.

Should women on testosterone be concerned about bone loss? Yes. Long‑term testosterone can affect bone remodeling, so regular bone density monitoring is advisable to prevent potential fractures.